Wei S M, Erdei J, Fülöp T, Robert L, Jacob M P
Laboratoire de Biologie du Tissu Conjonctif, UA CNRS 1460, Faculté de Médecine, Créteil, France.
J Immunol Methods. 1993 Sep 15;164(2):175-87. doi: 10.1016/0022-1759(93)90310-4.
Discrepancies exist between the reported values for the mean elastin peptide (EP) concentration in human sera. In order to understand these discrepancies, several EP preparations were obtained in vitro and monoclonal and polyclonal antibodies were produced against them. These different EP preparations and antibodies were used in an enzyme-linked immunosorbent assay (ELISA) to study cross-reactivity between EP preparations and to quantitate EP concentration in human sera. The method of purification of elastin, the method of hydrolysis of elastin and the molecular weight of EP influence their reactivity with antibodies and the results of EP measurements in human sera. However, there is a good correlation between EP measurements carried out in several human sera with the different EP preparations and different antibodies. Although absolute values of the EP concentrations varied with the EP preparation and antibodies used for the ELISA, the variations of this EP concentration measured from one human serum to another are significant.
人血清中弹性蛋白肽(EP)平均浓度的报告值之间存在差异。为了理解这些差异,在体外获得了几种EP制剂,并针对它们制备了单克隆抗体和多克隆抗体。这些不同的EP制剂和抗体用于酶联免疫吸附测定(ELISA),以研究EP制剂之间的交叉反应性,并定量人血清中的EP浓度。弹性蛋白的纯化方法、弹性蛋白的水解方法以及EP的分子量会影响它们与抗体的反应性以及人血清中EP测量的结果。然而,使用不同的EP制剂和不同的抗体在几个人血清中进行的EP测量之间存在良好的相关性。尽管EP浓度的绝对值因用于ELISA的EP制剂和抗体而异,但从一个人血清到另一个人血清测量的这种EP浓度变化是显著的。